- Home
- COYA vs SBI Comparison
COYA vs SBI Comparison
Compare COYA & SBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COYA
- SBI
- Stock Information
- Founded
- COYA 2020
- SBI 1992
- Country
- COYA United States
- SBI United States
- Employees
- COYA N/A
- SBI N/A
- Industry
- COYA Biotechnology: Pharmaceutical Preparations
- SBI Finance/Investors Services
- Sector
- COYA Health Care
- SBI Finance
- Exchange
- COYA Nasdaq
- SBI Nasdaq
- Market Cap
- COYA 125.1M
- SBI 111.4M
- IPO Year
- COYA 2022
- SBI N/A
- Fundamental
- Price
- COYA $6.16
- SBI $7.73
- Analyst Decision
- COYA Strong Buy
- SBI
- Analyst Count
- COYA 5
- SBI 0
- Target Price
- COYA $15.80
- SBI N/A
- AVG Volume (30 Days)
- COYA 203.6K
- SBI 39.5K
- Earning Date
- COYA 11-12-2025
- SBI 01-01-0001
- Dividend Yield
- COYA N/A
- SBI 4.52%
- EPS Growth
- COYA N/A
- SBI N/A
- EPS
- COYA N/A
- SBI N/A
- Revenue
- COYA $3,987,706.00
- SBI N/A
- Revenue This Year
- COYA $40.80
- SBI N/A
- Revenue Next Year
- COYA N/A
- SBI N/A
- P/E Ratio
- COYA N/A
- SBI N/A
- Revenue Growth
- COYA N/A
- SBI N/A
- 52 Week Low
- COYA $4.65
- SBI $6.96
- 52 Week High
- COYA $8.29
- SBI $8.00
- Technical
- Relative Strength Index (RSI)
- COYA 52.36
- SBI 27.16
- Support Level
- COYA $5.68
- SBI $7.67
- Resistance Level
- COYA $6.20
- SBI $7.91
- Average True Range (ATR)
- COYA 0.34
- SBI 0.05
- MACD
- COYA 0.02
- SBI -0.02
- Stochastic Oscillator
- COYA 86.38
- SBI 8.31
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
About SBI Western Asset Intermediate Muni Fund Inc
Western Asset Intermediate Muni Fd Inc is a diversified closed-end management investment company. The fund's objective is to provide a high level of current income exempt from Federal income taxes. Under normal market conditions, the Fund will invest at least 80% of its total assets in municipal obligations. In addition, under normal market conditions, the Fund will invest at least 80% of its total assets in debt securities that are, at the time of investment, rated investment grade by a nationally recognized statistical rating organization or, if unrated, of equivalent quality as determined by the investment manager. The Fund also maintains a dollar-weighted average effective maturity of between three and ten years.